$1,289.55 travel Payment -- Allergan (AbbVie) to Dr. Lisa Garcia
Allergan (AbbVie) covers travel and lodging for Plastic Surgeon Lisa Garcia related to Revlimid.
This page provides a detailed analysis of a $1,289.55 travel payment from Allergan (AbbVie) to Dr. Lisa Garcia. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $1,289.55 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Allergan (AbbVie) |
| Physician | Dr. Lisa Garcia |
| NPI Number | 1882399483 |
| Physician Specialty | Plastic Surgery |
| Location | Naperville, IL |
| Date of Payment | 2025-04-11 |
| Related Drug/Device | Revlimid |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Allergan (AbbVie) made a $1.3K travel payment to Lisa Garcia, a Plastic Surgery specialist in Naperville, IL. The payment was associated with Revlimid. The payment of $1,289.55 to Dr. Lisa Garcia from Allergan (AbbVie) was for travel and lodging related to Revlimid. This payment occurred on April 11, 2025, and was made by Allergan (AbbVie), a subsidiary of AbbVie. The payment was made to a Plastic Surgery specialist in Naperville, IL.
Patient Guidance: What This Payment Means for You
If you are a patient, understand that your doctor may receive travel and lodging support from pharmaceutical companies for educational purposes related to specific medications. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Travel and lodging payments to physicians can vary widely by specialty; Plastic Surgery may see such payments for educational events or consultations related to specific devices or drugs.
Regulatory Context: Sunshine Act Requirements
Payments for travel and lodging are reportable under the Sunshine Act, requiring disclosure of the nature of the payment and the associated drug or device.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- travel-expenses
- plastic-surgery
- drug-marketing
- open-payments-data
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $1.3K payment for?
This was a travel payment of $1.3K from Allergan (AbbVie) to Lisa Garcia, categorized as "Travel and Lodging". It was associated with Revlimid. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Lisa Garcia accept pharmaceutical money?
Yes, Lisa Garcia received this $1.3K payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Lisa Garcia's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $1.3K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Plastic Surgery?
To compare this payment against Plastic Surgery averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Plastic Surgery physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Lisa Garcia's relationship with Allergan (AbbVie)?
The payment covers 'Travel and Lodging', indicating expenses beyond direct speaking fees or consulting. This $1.3K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Plastic Surgery?
The specific drug mentioned, Revlimid, is a significant product for pharmaceutical companies.
What should patients do after learning about this payment?
If you are a patient, understand that your doctor may receive travel and lodging support from pharmaceutical companies for educational purposes related to specific medications.
What else should I know about this travel payment?
The payment date is in the future (2025), suggesting this might be a pre-approved expense or a placeholder.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.